Yasuhiro Nanri

779 total citations
22 papers, 555 citations indexed

About

Yasuhiro Nanri is a scholar working on Physiology, Dermatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yasuhiro Nanri has authored 22 papers receiving a total of 555 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Dermatology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yasuhiro Nanri's work include Asthma and respiratory diseases (9 papers), Dermatology and Skin Diseases (6 papers) and IL-33, ST2, and ILC Pathways (5 papers). Yasuhiro Nanri is often cited by papers focused on Asthma and respiratory diseases (9 papers), Dermatology and Skin Diseases (6 papers) and IL-33, ST2, and ILC Pathways (5 papers). Yasuhiro Nanri collaborates with scholars based in Japan, United States and Germany. Yasuhiro Nanri's co-authors include Satoshi Nunomura, Kenji Izuhara, Tomohito Yoshihara, Yasutaka Mitamura, Junya Ono, Masahiro Ogawa, Atsushi Kawaguchi, Simon J. Conway, Yukie Yamaguchi and Masutaka Furue and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Yasuhiro Nanri

20 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuhiro Nanri Japan 12 207 155 153 134 132 22 555
Tomohito Yoshihara Japan 10 132 0.6× 112 0.7× 109 0.7× 99 0.7× 78 0.6× 13 403
G.L. Jacob United States 13 200 1.0× 213 1.4× 70 0.5× 70 0.5× 183 1.4× 19 617
Morgan G. Blaylock United Kingdom 14 339 1.6× 215 1.4× 25 0.2× 271 2.0× 116 0.9× 19 728
Chian‐Yaw Hwang Taiwan 9 57 0.3× 33 0.2× 320 2.1× 104 0.8× 77 0.6× 12 539
Daniel J. Lenihan United States 7 198 1.0× 85 0.5× 20 0.1× 91 0.7× 65 0.5× 12 418
Noriaki Shinomiya Japan 10 88 0.4× 41 0.3× 84 0.5× 73 0.5× 72 0.5× 36 357
Kirsti McElwain United States 11 542 2.6× 333 2.1× 33 0.2× 376 2.8× 150 1.1× 11 886
Ioannis Morianos Greece 13 193 0.9× 106 0.7× 22 0.1× 306 2.3× 49 0.4× 21 667
Shauna McElwain United States 13 625 3.0× 402 2.6× 36 0.2× 429 3.2× 163 1.2× 13 1.0k
Lucy Woodman United Kingdom 14 632 3.1× 297 1.9× 58 0.4× 433 3.2× 182 1.4× 18 888

Countries citing papers authored by Yasuhiro Nanri

Since Specialization
Citations

This map shows the geographic impact of Yasuhiro Nanri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuhiro Nanri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuhiro Nanri more than expected).

Fields of papers citing papers by Yasuhiro Nanri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuhiro Nanri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuhiro Nanri. The network helps show where Yasuhiro Nanri may publish in the future.

Co-authorship network of co-authors of Yasuhiro Nanri

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuhiro Nanri. A scholar is included among the top collaborators of Yasuhiro Nanri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuhiro Nanri. Yasuhiro Nanri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nunomura, Satoshi, Yasuhiro Nanri, Takashi Akutagawa, et al.. (2025). Serum Periostin is Able to Stratify Type 2-Dominant Ulcerative Colitis. Inflammatory Bowel Diseases. 31(6). 1677–1689. 1 indexed citations
2.
Izuhara, Kenji, et al.. (2025). Mechanism of transduction of itch and strategy of treatment for itch. Folia Pharmacologica Japonica. 160(2). 79–85.
3.
Nunomura, Satoshi, Daisuke Uta, Isao Kitajima, et al.. (2023). Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway. Cell Reports. 42(1). 111933–111933. 13 indexed citations
4.
Nanri, Yasuhiro, et al.. (2022). A Positive Loop Formed by SOX11 and Periostin Upregulates TGF-β Signals Leading to Skin Fibrosis. Journal of Investigative Dermatology. 143(6). 989–998.e7. 6 indexed citations
5.
Nunomura, Satoshi, et al.. (2021). The FADS mouse: A novel mouse model of atopic keratoconjunctivitis. Journal of Allergy and Clinical Immunology. 148(6). 1596–1602.e1. 7 indexed citations
6.
Nunomura, Satoshi, Yasuhiro Nanri, Véronique Lefebvre, & Kenji Izuhara. (2021). Epithelial SOX11 regulates eyelid closure during embryonic eye development. Biochemical and Biophysical Research Communications. 549. 27–33. 1 indexed citations
7.
Yoshihara, Tomohito, Yasuhiro Nanri, Satoshi Nunomura, et al.. (2020). Periostin plays a critical role in the cell cycle in lung fibroblasts. Respiratory Research. 21(1). 38–38. 30 indexed citations
8.
Izuhara, Kenji, et al.. (2019). Periostin: An emerging biomarker for allergic diseases. Allergy. 74(11). 2116–2128. 96 indexed citations
9.
Nanri, Yasuhiro, Satoshi Nunomura, Yasuhiro Terasaki, et al.. (2019). Cross-Talk between Transforming Growth Factor-β and Periostin Can Be Targeted for Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 62(2). 204–216. 45 indexed citations
10.
Nunomura, Satoshi, Yasuhiro Nanri, Kazuhiko Arima, et al.. (2019). Establishment of a Mouse Model of Atopic Dermatitis by Deleting Ikk2 in Dermal Fibroblasts. Journal of Investigative Dermatology. 139(6). 1274–1283. 15 indexed citations
11.
Ono, Junya, Satoshi Nunomura, Yasuhiro Nanri, et al.. (2019). Periostin forms a functional complex with IgA in human serum. Allergology International. 69(1). 111–120. 8 indexed citations
12.
Nanri, Yasuhiro, Satoshi Nunomura, Yasuhiro Terasaki, et al.. (2019). The cross-talk between TGF-ß and periostin can be targeted for pulmonary fibrosis. PA1292–PA1292.
13.
Mitamura, Yasutaka, Satoshi Nunomura, Yasuhiro Nanri, et al.. (2018). The IL‐13/periostin/IL‐24 pathway causes epidermal barrier dysfunction in allergic skin inflammation. Allergy. 73(9). 1881–1891. 101 indexed citations
14.
Izuhara, Kenji, Yukie Yamaguchi, Shoichiro Ohta, et al.. (2018). Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases. International Journal of Molecular Sciences. 19(4). 1102–1102. 41 indexed citations
15.
Mitamura, Yasutaka, Satoshi Nunomura, Yasuhiro Nanri, et al.. (2018). Hierarchical control of interleukin 13 (IL-13) signals in lung fibroblasts by STAT6 and SOX11. Journal of Biological Chemistry. 293(38). 14646–14658. 27 indexed citations
16.
Izuhara, Kenji, Shoichi Suzuki, Masahiro Ogawa, et al.. (2017). The Significance of Hypothiocyanite Production via the Pendrin/DUOX/Peroxidase Pathway in the Pathogenesis of Asthma. Oxidative Medicine and Cellular Longevity. 2017(1). 1054801–1054801. 11 indexed citations
17.
Izuhara, Kenji, Satoshi Nunomura, Yasuhiro Nanri, et al.. (2017). Periostin in inflammation and allergy. Cellular and Molecular Life Sciences. 74(23). 4293–4303. 116 indexed citations
18.
Komiya, Kosaku, Shoichiro Ohta, Kazuhiko Arima, et al.. (2017). Clarithromycin attenuates IL-13–induced periostin production in human lung fibroblasts. Respiratory Research. 18(1). 37–37. 16 indexed citations
19.
Suzuki, Shoichi, Masahiro Ogawa, Shoichiro Ohta, et al.. (2016). Induction of Airway Allergic Inflammation by Hypothiocyanite via Epithelial Cells. Journal of Biological Chemistry. 291(53). 27219–27227. 17 indexed citations
20.
Nanri, Yasuhiro, et al.. (2007). [Percutaneous transpedicular vertebroplasty and kyphoplasty for osteoporotic vertebral compression fractures].. PubMed. 65 Suppl 9. 471–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohito Yoshihara Breakdown of academic impact, for papers by G.L. Jacob Breakdown of academic impact, for papers by Morgan G. Blaylock Breakdown of academic impact, for papers by Chian‐Yaw Hwang Breakdown of academic impact, for papers by Daniel J. Lenihan Breakdown of academic impact, for papers by Noriaki Shinomiya Breakdown of academic impact, for papers by Kirsti McElwain Breakdown of academic impact, for papers by Ioannis Morianos Breakdown of academic impact, for papers by Shauna McElwain Breakdown of academic impact, for papers by Lucy Woodman
Rankless by CCL
2026